TY - JOUR AU - Wagneur, Nicolas AU - Callier, Patrick AU - Zeitoun, Jean-David AU - Silber, Denise AU - Sabatier, Remi AU - Denis, Fabrice PY - 2022 DA - 2022/7/5 TI -评估一种新的预筛选分数，用于简化评估eHealth应用程序的临床质量和相关性:仪器验证研究乔- J地中海互联网Res SP - e39590六世24 - 7 KW -得分KW -电子健康KW -临床意义KW -解决方案KW -数字解决方案KW -临床验证千瓦试销KW -电子健康应用KW -医学数字解决方案KW -评分工具KW -健康应用KW -信息质量AB -背景:2020年,超过250电子健康解决方案添加到应用程序商店每一天,在今年或90000年;然而，绝大多数这些溶液没有经过临床验证，其质量未知，用户不知道它们是否有效和安全。我们试图开发一种简单的预筛选评分方法，用于评估每个应用程序的质量和临床相关性。我们在设计这个工具时考虑了3个医疗保健利益相关者群体:寻求评估潜在竞争对手或他们自己的工具的电子健康解决方案设计师，考虑筹资候选人的投资者，以及希望评估当前或潜在电子健康解决方案的医院临床医生或IT部门。目的:我们构建和测试一种新的预筛选评分工具(医疗数字解决方案评分工具)。该工具由26个问题组成，能够快速评估和比较电子健康应用程序的临床相关性和质量，并在68个电子健康解决方案上进行了测试。方法:医疗数字解决方案评分工具基于法国国家卫生局2021年的评价标准、2022年欧洲肿瘤医学协会的建议和其他提供的评分。我们与患者协会和eHealth专家一起构建了评分工具，并将其提交给eHealth应用程序创建者，他们于2022年1月通过基于web的表单评估他们的应用程序。在完成评价标准后，他们的应用程序获得了总分和4类子得分。这些标准评估了解决方案的类型和领域、解决方案的目标人群规模、临床评估水平和有关提供者的信息。 Results: In total, 68 eHealth solutions were evaluated with the scoring tool. Oncology apps (22%, 20/90) and general health solutions (23%, 21/90) were the most represented. Of the 68 apps, 32 (47%) were involved in remote monitoring by health professionals. Regarding clinical outcomes, 5% (9/169) of the apps assessed overall survival. Randomized studies had been conducted for 21% (23/110) of the apps to assess their benefit. Of the 68 providers, 38 (56%) declared the objective of obtaining reimbursement, and 7 (18%) out of the 38 solutions seeking reimbursement were assessed as having a high probability of reimbursement. The median global score was 11.2 (range 4.7-17.4) out of 20 and the distribution of the scores followed a normal distribution pattern (Shapiro-Wilk test: P=.33). Conclusions: This multidomain prescreening scoring tool is simple, fast, and can be deployed on a large scale to initiate an assessment of the clinical relevance and quality of a clinical eHealth app. This simple tool can help a decision-maker determine which aspects of the app require further analysis and improvement. SN - 1438-8871 UR - //www.mybigtv.com/2022/7/e39590 UR - https://doi.org/10.2196/39590 UR - http://www.ncbi.nlm.nih.gov/pubmed/35788102 DO - 10.2196/39590 ID - info:doi/10.2196/39590 ER -